How the Law has Failed Children of Anonymous Sperm Donors
By Sarah Dingle,
Daily Life [Australia]
| 06. 30. 2015
Untitled Document
Something happened over the weekend in Melbourne which has never happened anywhere before in the world. This is the future come home to roost. For decades, medicine has created miracle babies, while pretending that biology doesn't matter. The time for that pretence is over. Now it's time for the truth.
On Saturday, donor conceived offspring gathered from all around Australia – and some came from overseas – for the country's first National Conference for Donor Conceived People. (We call ourselves 'DC', which is a less socially awkward shorthand for 'people conceived using donor sperm or a donated egg'.) It's the first time in the world that such a gathering has been organised by DC people themselves. You know what that says? The experiment has grown up. Forty years after this industry really got going, we're no longer just donor conceived children. We are donor conceived children, teens, and adults, some with children of our own. Just like adoptees, we want to know who our biological families are, and what our medical history is. We want to know whose genes we have. We have a right to...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...